Artificial intelligence (AI) potential in early lung cancer detection.
ABBV-400 by AbbVie for Bile Duct Cancer (Cholangiocarcinoma): Likelihood of Approval
Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug